PMC:7696151 / 97276-97543
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2831 | 17-20 | Chemical | denotes | HCQ | MESH:D006886 |
| 2832 | 186-198 | Chemical | denotes | methotrexate | MESH:D008727 |
| 2846 | 66-85 | Disease | denotes | autoimmune diseases | MESH:D001327 |
| 2847 | 94-114 | Disease | denotes | rheumatoid arthritis | MESH:D001172 |
| 2848 | 116-135 | Disease | denotes | lupus erythematosus | MESH:D008180 |
| 2849 | 141-157 | Disease | denotes | Sjögren syndrome | MESH:D012859 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T243 | 66-85 | Phenotype | denotes | autoimmune diseases | http://purl.obolibrary.org/obo/HP_0002960 |
| T244 | 94-114 | Phenotype | denotes | rheumatoid arthritis | http://purl.obolibrary.org/obo/HP_0001370 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T622 | 0-267 | Sentence | denotes | Hence, nowadays, HCQ arises as a first-line treatment in managing autoimmune diseases such as rheumatoid arthritis, lupus erythematosus, and Sjögren syndrome, mainly in association with methotrexate or corticosteroids, showing a synergistic effect on disease control. |